These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 6488267)

  • 1. [High doses of cytosine arabinoside--a new use for an old drug].
    Klener P
    Cas Lek Cesk; 1984 Jul; 123(29):907. PubMed ID: 6488267
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of leukemia with cytosine arabinoside--on the intensification of remission].
    Tatsumi N; Masaoka T; Ueda Y; Senda N
    Gan No Rinsho; 1970 Jul; 16(7):706-12. PubMed ID: 5465488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose cytosine arabinoside therapy in refractory acute leukemia].
    Yorimitsu S; Takahashi I; Kitazima K; Kimura I; Hara M; Tokuda M
    Rinsho Ketsueki; 1984 Dec; 25(12):1941-6. PubMed ID: 6533329
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neutropenic typhlitis: a frequently missed complication of aplasia-inducing tumor therapy with a possible association to the combination of etoposide with high-dose cytosine-arabinoside].
    Benz G; Gmür J; Gubler J
    Schweiz Med Wochenschr; 1994 Feb; 124(5):186-92. PubMed ID: 8128200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypoplastic leukemia achieved long-term remission with low-dose cytosine arabinoside].
    Fujisawa S; Kanamori H; Noguchi T; Maruta A; Ogawa K; Sakai R; Taguchi J; Tomita N; Kodama F; Okubo T
    Rinsho Ketsueki; 1995 Jan; 36(1):56-8. PubMed ID: 7715078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much is too much high-dose cytosine arabinoside?
    Duffy TP
    J Clin Oncol; 1985 May; 3(5):601-3. PubMed ID: 3998778
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary evaluation of adverse effects after administration of arabinoside cytosine (Ara-C) in high doses to children with acute myelogenous leukemia].
    Wysocki M; Kurylak A; Pilecki O; Balcar-Boroń A
    Acta Haematol Pol; 1994; 25(1):37-42. PubMed ID: 8209612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low-dose cytosine arabinoside (Ara-C) continuous infusion regimen for atypical nonlymphocytic leukemia--clinical study of the remission mechanism by serial chromosomal findings, colony formation and plasma Ara-C concentration].
    Tagawa M; Tomonaga M; Shibata J; Nishino K; Nonaka H; Ikeda S; Suzuyama J; Amenomori T; Matuo T; Kuriyama K
    Rinsho Ketsueki; 1984 Oct; 25(10):1606-17. PubMed ID: 6520937
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
    Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
    Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabine.
    Kaplan HG; Appelbaum FR; Cheever MA; Greenberg PD; Wood T; Fefer A
    Cancer Treat Rep; 1982 Jun; 66(6):1397-8. PubMed ID: 7083242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar toxicities associated with cytosine arabinoside: a nursing perspective.
    Conrad KJ
    Oncol Nurs Forum; 1986; 13(5):57-9. PubMed ID: 3638720
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology and human antitumor activity of cytosine arabinoside.
    Talley RW; O'Bryan RM; Tucker WG; Loo RV
    Cancer; 1967 May; 20(5):809-16. PubMed ID: 6071587
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
    Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
    J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside].
    Weil M; Auclerc MF; Schaison G; Auclerc G; Daubrisson A; Degos L; Caro J; Marty M; Jacquillat GI
    Nouv Presse Med; 1982 Oct; 11(39):2911-4. PubMed ID: 6755389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.
    Openshaw H; Slatkin NE; Stein AS; Hinton DR; Forman SJ
    Cancer; 1996 Nov; 78(9):1899-905. PubMed ID: 8909309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduced dosage of cytosine arabinoside in the treatment of acute myelocytic leukemia. Apropos of 3 cases].
    Andrey C; Beris P; Plancherel C; de Loes S; Maurice P; Chapuis B
    Schweiz Med Wochenschr; 1983 Jul; 113(27-28):980-4. PubMed ID: 6577584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study.
    Winkelman MD; Hines JD
    Ann Neurol; 1983 Nov; 14(5):520-7. PubMed ID: 6651239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose cytosine arabinoside in the treatment of acute nonlymphocytic leukemia.
    Cavanna L; Di Stasi M; Fornari F; Civardi G; Sholli G; Montanari G; Buscarini L
    Acta Haematol; 1988; 79(3):179-80. PubMed ID: 3128043
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new agent active in the treatment of acute leukemia: cytosine arabinoside].
    Bernard J; Boiron M; Jacquillat C; Weil M; Najean Y
    Presse Med (1893); 1966 Mar; 74(16):799-802. PubMed ID: 5907421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.